LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 59.85 | 27.76 | 97 | 6062 | 0.0160 | 0.1747 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 59.85 | 27.76 | 2807 | 6062 | 0.4630 | 0.8113 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 59.85 | 27.76 | 163 | 6062 | 0.0269 | 0.2558 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 59.85 | 27.76 | 3304 | 6062 | 0.5450 | 0.8497 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 61.56 | 27.76 | 114 | 6217 | 0.0183 | 0.1984 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 61.56 | 27.76 | 2907 | 6217 | 0.4676 | 0.8144 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 61.56 | 27.76 | 148 | 6217 | 0.0238 | 0.2391 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 61.56 | 27.76 | 3440 | 6217 | 0.5533 | 0.8540 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.26 | 27.76 | 105 | 6465 | 0.0162 | 0.1843 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.26 | 27.76 | 2976 | 6465 | 0.4603 | 0.8121 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.26 | 27.76 | 166 | 6465 | 0.0257 | 0.2554 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.26 | 27.76 | 3592 | 6465 | 0.5556 | 0.8560 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.97 | 27.76 | 93 | 6656 | 0.0140 | 0.1653 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.97 | 27.76 | 3114 | 6656 | 0.4678 | 0.8168 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.97 | 27.76 | 165 | 6656 | 0.0248 | 0.2529 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.97 | 27.76 | 3736 | 6656 | 0.5612 | 0.8591 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 66.67 | 27.76 | 81 | 6695 | 0.0121 | 0.1449 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 66.67 | 27.76 | 3209 | 6695 | 0.4793 | 0.8225 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 66.67 | 27.76 | 158 | 6695 | 0.0236 | 0.2458 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 66.67 | 27.76 | 3921 | 6695 | 0.5856 | 0.8692 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 68.37 | 27.76 | 85 | 6879 | 0.0124 | 0.1511 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 68.37 | 27.76 | 3334 | 6879 | 0.4847 | 0.8259 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 68.37 | 27.76 | 160 | 6879 | 0.0233 | 0.2464 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 68.37 | 27.76 | 4098 | 6879 | 0.5957 | 0.8739 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.08 | 27.76 | 65 | 6849 | 0.0095 | 0.1130 | MN20160318_Q01 | E22 |